T-Cell Prolymphocytic Leukemia Involving Lymph Nodes and Other Tissues
T-cell prolymphocytic leukemia (T-PLL) is an aggressive T-cell leukemia composed of small- to medium-sized prolymphocytes with a mature T-cell immunophenotype. T-PLL represents ~2 % of mature lymphocytic leukemias. This neoplasm affects mostly adults, with a median age of 65 years (range, 30–94 years) and a male to female ratio of 2:1. Patients with ataxia telangiectasia are at increased risk of developing T-PLL. Most patients present with B-symptoms, hepatosplenomegaly, and generalized lymphadenopathy. Patients commonly have marked leukocytosis and the lymphocyte count usually exceeds 100 × 109/L. Anemia and thrombocytopenia also occur, but less commonly. Serologic testing for human T-cell leukemia virus type 1 (HTLV-1) is negative.
KeywordsLeukemia Anemia Thrombocytopenia Alemtuzumab Campath
- 1.Muzzafar T, Medeiros LJ. T-cell prolymphocytic leukemia involving lymph node and other tissues. In: Medeiros LJ, editor. Diagnostic pathology, lymph nodes and spleen with extranodal lymphomas. 1st ed. Altona: Amirsys; 2011. p. 10-72–9.Google Scholar
- 2.Catovsky D, Muller-Hermelink HK, Ralfkiaer E. T-cell prolymphocytic leukaemia. In: Swerdlow SH, Harris NL, Jaffe ES, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008. p. 270–1.Google Scholar
- 6.Herling M, Khoury JD, Washington LT, et al. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004;104(2):328–35.Google Scholar